Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion type Assertion NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_head.
- NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_provenance.
- NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion evidence source_evidence_literature NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_provenance.
- NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion SIO_000772 23453647 NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_provenance.
- NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion wasDerivedFrom befree-20150227 NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_provenance.
- NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_assertion wasGeneratedBy ECO_0000203 NP890503.RA4J41JrAZQyCGeZJcI7XY_rOMZH3ZuX0_CasmJ4p-B54130_provenance.